Page last updated: 2024-08-23

cefoperazone and Pneumonia, Ventilator-Associated

cefoperazone has been researched along with Pneumonia, Ventilator-Associated in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, CH; Chen, CM; Chen, WC; Fang, WF; Fu, PK; Huang, CT; Ku, SC; Kuo, LK; Lai, CC; Tu, CY; Wang, YT1
Fu, L; Qin, Y; Wu, L; Xue, X; Zhang, D; Zhang, J1
Li, HX; Li, TZ; Wang, LW; Zou, L1
Altın, N; Argun, C; Canbakan, B; Cesur, S; Koldaş, K; Kurşun, O; Sencan, I; Unal, N1

Trials

1 trial(s) available for cefoperazone and Pneumonia, Ventilator-Associated

ArticleYear
Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
    International journal of clinical pharmacology and therapeutics, 2018, Volume: 56, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Cefoperazone; Cohort Studies; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Prospective Studies; Sulbactam; Tigecycline; Treatment Outcome

2018

Other Studies

3 other study(ies) available for cefoperazone and Pneumonia, Ventilator-Associated

ArticleYear
Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
    International journal of antimicrobial agents, 2022, Volume: 59, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cohort Studies; Community-Acquired Infections; Female; Frail Elderly; Healthcare-Associated Pneumonia; Humans; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Treatment Outcome

2022
[Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2014, Volume: 36, Issue:2

    Topics: Acinetobacter baumannii; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Minocycline; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Treatment Outcome

2014
[A case of ventilator-associated pneumonia due to Pantoea agglomerans].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:2

    Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Heart Arrest; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ofloxacin; Opportunistic Infections; Pantoea; Pneumonia, Ventilator-Associated; Respiration, Artificial; Sulbactam

2012